CriticalImmunosuppressants. Calcineurin inhibitors×Third-generation dihydropyridine calcium channel blocker
Updated · Methodology
Mechanism
The liver breaks down lercanidipine through the enzyme CYP3A4, and ciclosporin inhibits CYP3A4 and the transporter P-glycoprotein (lercanidipine and ciclosporin summaries of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). When the two drugs were taken together, lercanidipine plasma levels rose threefold and the area under the concentration curve (AUC) of ciclosporin rose by 21% (lercanidipine and ciclosporin SmPCs, AEMPS). When ciclosporin was given 3 hours after lercanidipine, lercanidipine levels did not change, but ciclosporin AUC still rose by 27% (lercanidipine and ciclosporin SmPCs, AEMPS). The higher the lercanidipine level, the more it lowers blood pressure. In overdose, lercanidipine causes excessive peripheral vasodilation and reflex tachycardia (lercanidipine SmPC, AEMPS). The effects of ciclosporin on the kidneys and liver depend on the dose (ciclosporin SmPC, AEMPS).
Symptoms
Excess lercanidipine causes low blood pressure, dizziness, headache and palpitations. At very high doses, the heart rate may instead slow and heart contractility may fall (lercanidipine summary of product characteristics, SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS). The most common adverse effects of lercanidipine are peripheral oedema, headache, flushing, fast heart rate and palpitations (lercanidipine SmPC, AEMPS). Higher ciclosporin levels may show as rising blood creatinine and urea, and as rising bilirubin and liver enzymes (ciclosporin SmPC, AEMPS).
Management
The combination is contraindicated. Ciclosporin appears among the contraindications in the summaries of product characteristics (SmPCs) of lercanidipine, both the original product and a generic, and under their interaction section the two drugs must not be taken together (lercanidipine SmPCs, Spanish Agency of Medicines and Medical Devices, AEMPS). The ciclosporin SmPC is softer. Under it, simultaneous intake should be avoided, and if the drugs are taken at least 3 hours apart, the combination is given with caution, because the area under the concentration curve (AUC) of ciclosporin still rises by 27% (ciclosporin SmPC, AEMPS). During ciclosporin treatment, check blood pressure regularly. If hypertension develops, choose an antihypertensive that does not change ciclosporin pharmacokinetics, such as isradipine (ciclosporin SmPC, AEMPS). In transplant patients, measure ciclosporin levels often and adjust the dose if needed, especially when other drugs are started or stopped (ciclosporin SmPC, AEMPS). In non-transplant patients taking drugs that raise ciclosporin levels, frequent kidney function checks and close watch for ciclosporin adverse effects may be more useful than measuring levels (ciclosporin SmPC, AEMPS). If blood pressure falls sharply after the two drugs have been taken together, give active cardiovascular support and monitor the cardiovascular status for at least 24 hours, because lercanidipine acts for a long time (lercanidipine SmPC, AEMPS).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- AEMPS: Ficha técnica: Lercanidipino (nº registro 61653), sección 4.3 (2021)– AEMPS, CIMA, nº registro 61653 (Zanidip 10 mg comprimidos recubiertos con película, Casen Recordati), revisión 12/2021, secciones 4.3, 4.5, 4.8 y 4.9
- AEMPS: Ficha técnica: Ciclosporina (nº registro 60320), sección 4.4 (2026)– AEMPS, CIMA, nº registro 60320 (Sandimmun Neoral 100 mg cápsulas blandas, Novartis), revisión 05/2026, secciones 4.4 y 4.5